| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.17 | 0.0004 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |